Lexaria Bioscience Announces Results From Research Collaboration With National Research Council Of Canada, Demonstrating DehydraTECH's Ability To Preserve Monomeric Form Of GLP-1 Drug Semaglutide
Lexaria Bioscience Announces Results From Research Collaboration With National Research Council Of Canada, Demonstrating DehydraTECH's Ability To Preserve Monomeric Form Of GLP-1 Drug Semaglutide
Lexaria Bioscience宣佈與加拿大國家研究委員會展開的研究合作結果，展示出DehydraTECH保存GLP-1藥物Semaglutide單體形態的能力。
Lexaria Bioscience Announces Results From Research Collaboration With National Research Council Of Canada, Demonstrating DehydraTECH's Ability To Preserve Monomeric Form Of GLP-1 Drug Semaglutide
Lexaria Bioscience宣佈與加拿大國家研究委員會展開的研究合作結果，展示出DehydraTECH保存GLP-1藥物Semaglutide單體形態的能力。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。